FDA declines approval bid for Neffy, a needle-free EpiPen alternative
ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.
Epipen
FDA rejects approval of epinephrine nasal spray
The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe allergic reactions. The FDA said Neffy needs more research.
In-flight emergencies raise concerns about airlines' medical kit requirements
About one out of every 600 flights has an in-flight medical emergency, one report found.
Reported EpiPen failures
Mylan, the drug company that created outrage with the dramatic price hike of the EpiPen, is on the defensive again. A new report shows a big rise in complaints about the device not working in life-threatening emergencies. Tony Dokoupil reports.
EpiPen competition
Prices for the EpiPen have soared more than 480% in the past 7 years. Now, generic brands and versions from other companies gaining market share. CBS News correspondent Anna Werner joins CBSN to discuss confusion over the cost of the emergency allergy treatment.
Prices of EpiPen alternatives
There are now more choices for millions of people who relied on the EpiPen for life-threatening allergies, but there is still confusion over the treatments' costs. The Auvi-Q is an epinephrine auto-injector alternative that's listed as $4,500 for a two-pack. But most patients aren't paying a penny of that, leading to the question: who is? Anna Werner reports.
Latest MoneyWatch headlines
U.S. labor market on fire, latest job numbers suggests; EpiPen makers accused of $1.3B gov't ripoff; and 1 in 4 U.S. malls could close in next decade. These headlines and more from CBS MoneyWatch.
MoneyWatch headlines
U.S. GDP shrank in fourth quarter; Trump administration weighs Mexico tariff; and Mylan CEO understands public concerns about drug costs. These headlines and more from CBS MoneyWatch.
Mylan CEO on EpiPen price hike
Pharmaceutical giant Mylan was at the center of criticism last year over rising drug prices. Its EpiPen became the lightning rod for scrutiny, as the life-saving allergy drug's price increased by nearly 500 percent over seven years. In her first in-depth interview since giving testimony before Congress, Mylan CEO Heather Bresch talks to Norah O'Donnell and responds to the outrage among lawmakers and consumers.
Mylan CEO on competition
Heather Bresch, who was called before Congress last year to explain why EpiPen's price had soared by nearly 500 percent over seven years, tells Norah O'Donnell why a competing product on the market doesn't necessarily bring prices down.
Mylan CEO on EpiPen controversy
Mylan CEO Heather Bresch is opening up about the firestorm created by the nearly-500 percent increase in the price of EpiPens. She was called to testify before Congress last year about the $600 price tag for the life-saving allergy medicine. In an interview with Norah O'Donnell, Bresch told us bigger change is needed to fix what she calls a broken healthcare system. Watch the full interview Friday on "CBS This Morning."
EpiPen price hike hearing
On Capitol Hill, Mylan CEO Heather Bresch strongly defended the EpiPen's nearly-500 percent price hike, testifying under oath. CBS News reviewed documents the company turned over to lawmakers that showed how much Mylan expected the EpiPen to generate in net sales this year. Vinita Nair reports.
Mylan EpiPen prices
Mylan CEO Heather Bresch faced bipartisan backlash for her company's pricing and revenue strategy on Wednesday on Capitol Hill. The price of EpiPens has increased from about $100 for a two pack to more than $600. Vinita Nair reports.
EpiPen price hike
New controversy swirls around the maker of the EpiPen, as the mother of Mylan CEO Heather Bresch reportedly helped the company establish a near-monopoly in schools, as the head of a national education group. CBS News' reporting last month on the nearly-500 percent price hike on the EpiPen prompted widespread public backlash, and Bresch is set to testify today on Capitol Hill about the price increase. Vinita Nair reports.
Generic EpiPen
The maker of EpiPen says it will release a generic version of the live-saving drug that will cost roughly half of the original price. WCBS medical correspondent Dr. Max Gomez joins CBSN to discuss the alternative option.
EpiPen price hike
Mylan CEO Heather Bresch went on the offensive Thursday as the company announced it would provide consumers a discount for the EpiPen. The pharmaceutical company has raised the price of the life-saving device by 500% since 2009. Vinita Nair reports.
Latest MoneyWatch headlines
Mylan to expand discounts for EpiPen drug amid backlash; Obama administration defends Affordable Care Act program; Facebook to target WhatsApp users with ads. These headlines and more from CBS MoneyWatch.
EpiPen maker accused of gouging consumers, and other MoneyWatch headlines
Lawmakers blast Mylan for nearly 500% hike in price of life-saving EpiPen drug; Tesla anoints Model S world's fastest production car; and McDonald's recalls fitness bands. These headlines and more from CBS MoneyWatch.
EpiPen price hike
The maker of EpiPen, a potentially life-saving medical device for severe allergic reactions, is now under Congressional scrutiny over how its cost has risen nearly 500 percent since 2009. But one prominent and controversial figure, former pharma CEO Martin Shkreli who has no connections to the EpiPen product, is defending the increase. Vinita Nair reports.
Martin Shkreli on EpiPen
In a conversation with CBS News' Vinita Nair, controversial former CEO of Turing Pharmaceuticals defends drug-maker Mylan for its skyrocketing cost of the device that delivers a life-saving injection for people with severe allergies. Shkreli has no connection with the EpiPen product. He also claims he is "innocent" of his own, unrelated federal securities fraud charges.
8/23: Evening News
Donald Trump is re-tooling his controversial immigration policy, which included a vow to deport 11 million undocumented immigrants; Mississippi firefighter Patrick Hardison's life changed in 2001 when the roof of a burning house collapsed on him
Shkreli on EpiPen
Several members of Congress are demanding to know why the price of EpiPens has skyrocketed by 500 percent. The devices deliver a life-saving injection for people with severe allergies. Vinita Nair spoke with a former pharmaceutical exec who faced similar criticism last year.
Martin Shkreli interview
The cost of EpiPens are on the rise. Founder and former CEO of Turing Pharmaceuticals, Martin Shkreli, joins CBSN with to discuss why he believes the price hike is justified and why he raised the price of Daraprim by 5000%.
EpiPen price soaring
Families with severe allergies often rely on EpiPens to deliver a dose of potentially life-saving medicine if a child has a bad reaction. But the cost of the EpiPen is surging, having risen by more than 480 percent since 2009, putting the pinch on many families. Vinita Nair reports.
Pfizer buying Mylan to create generic drug giant
Pfizer will split off its Upjohn unit, which makes Lipitor, to create a business with at least $19 billion in sales
Live
Trump says Iran war could wrap up in 2-3 weeks as gas prices rise
President Trump indicated the Iran war may wrap up "very soon" and he could abandon efforts to force Iran to reopen the Strait of Hormuz, as the war pushes U.S. gas prices over $4.
Trump signs order on mail-in ballots and federally run voter lists
President Trump has long wanted to place additional restrictions on mail-in voting, which he has called "mail-in cheating."
Jamie Dimon says AI could help shorten work week, cure cancer
JPMorgan CEO Jamie Dimon thinks AI will shorten the work week and lead to medical breakthroughs, while acknowledging the technology's potential impact on the nation's workforce.
Trump to give "important update on Iran" tonight in prime-time speech
President Trump is planning to deliver a prime-time address Wednesday night to "provide an important update on Iran," the White House said, as the president faces critical decisions in the monthlong war.
American journalist Shelly Kittleson kidnapped in Iraq
American journalist Shelly Kittleson was kidnapped in Baghdad on Tuesday, according to two sources familiar with the matter as well as an Iraqi official.
Trump plans to attend Supreme Court arguments in birthright citizenship case
President Trump is planning to go to the Supreme Court on Wednesday as the justices take up his executive order seeking to end birthright citizenship, a major test of his immigration agenda.
Jamie Dimon says rejecting capitalism is "dead wrong" in CBS News interview
JPMorgan Chase CEO Jamie Dimon shares his thinking on capitalism, AI, prediction markets and more in an interview with "CBS Evening News" anchor Tony Dokoupil.
Hegseth lifts suspension of Army pilots who flew by Kid Rock's house
Just hours earlier, an Army spokesperson said the crew had been suspended from flying while the Army conducts a formal investigation into why the Apache helicopters flew near Kid Rock's Nashville house.
Tiger Woods says he's "stepping away" to seek treatment after car crash
Tiger Woods announced Tuesday that he's "stepping away for a period of time to seek treatment" after pleading not guilty to charges including driving under the influence.
U.S.
More U.S.
Hegseth lifts suspension of Army pilots who flew by Kid Rock's house
Just hours earlier, an Army spokesperson said the crew had been suspended from flying while the Army conducts a formal investigation into why the Apache helicopters flew near Kid Rock's Nashville house.
Tiger Woods says he's "stepping away" to seek treatment after car crash
Tiger Woods announced Tuesday that he's "stepping away for a period of time to seek treatment" after pleading not guilty to charges including driving under the influence.
Jamie Dimon says rejecting capitalism is "dead wrong" in CBS News interview
JPMorgan Chase CEO Jamie Dimon shares his thinking on capitalism, AI, prediction markets and more in an interview with "CBS Evening News" anchor Tony Dokoupil.
Jamie Dimon: JPMorgan could offer prediction market services to investors
The JPMorgan Chase CEO said the bank may one day introduce prediction market features, but said "there's a bunch of stuff we won't do" in that space.
Trump signs order on mail-in ballots and federally run voter lists
President Trump has long wanted to place additional restrictions on mail-in voting, which he has called "mail-in cheating."
MoneyWatch
More MoneyWatch
Jamie Dimon says rejecting capitalism is "dead wrong" in CBS News interview
JPMorgan Chase CEO Jamie Dimon shares his thinking on capitalism, AI, prediction markets and more in an interview with "CBS Evening News" anchor Tony Dokoupil.
Jamie Dimon: JPMorgan could offer prediction market services to investors
The JPMorgan Chase CEO said the bank may one day introduce prediction market features, but said "there's a bunch of stuff we won't do" in that space.
Jamie Dimon says AI could help shorten work week, cure cancer
JPMorgan CEO Jamie Dimon thinks AI will shorten the work week and lead to medical breakthroughs, while acknowledging the technology's potential impact on the nation's workforce.
Americans saving less for retirement — that's a "warning sign," experts say.
Full-time employees cut their 401(k) participation and contribution rates last year amid an affordability crunch, new research shows.
Jamie Dimon: I don't know if Iran war will be "tipping point" for recession
Jamie Dimon told "CBS Evening News" anchor Tony Dokoupil that "what's more important for the future of the world is that this war successfully conclude."
Politics
More Politics
Trump plans to attend Supreme Court arguments in birthright citizenship case
President Trump is planning to go to the Supreme Court on Wednesday as the justices take up his executive order seeking to end birthright citizenship, a major test of his immigration agenda.
Judge orders Trump admin. to restore legal status of migrants allowed in under Biden
A federal judge directed the Trump administration to restore the legal status of migrants allowed into the U.S. under a now-defunct Biden administration program for asylum-seekers who arrived at the southern border.
Trump to give "important update on Iran" tonight in prime-time speech
President Trump is planning to deliver a prime-time address Wednesday night to "provide an important update on Iran," the White House said, as the president faces critical decisions in the monthlong war.
Hegseth lifts suspension of Army pilots who flew by Kid Rock's house
Just hours earlier, an Army spokesperson said the crew had been suspended from flying while the Army conducts a formal investigation into why the Apache helicopters flew near Kid Rock's Nashville house.
Trump signs order on mail-in ballots and federally run voter lists
President Trump has long wanted to place additional restrictions on mail-in voting, which he has called "mail-in cheating."
HealthWatch
More HealthWatch
States pay contractors millions to comply with Trump law to cut Medicaid rolls
The One Big Beautiful Bill Act will add red tape and restrictions for those seeking Medicaid and SNAP benefits. And the costs to update computer systems that determine eligibility for those programs will be steep.
Hockey player diagnosed with Stage IV cancer at 26: "It was surreal"
David Lyon is one of the rising number of young adults to be diagnosed with colorectal cancer.
What to know about the "wild, wild West" of viral peptide claims
Here's what to know about peptides, what they can and can't do, and what's driving viral claims about possible health benefits online.
CDC's acting chief promises a return to stability in a tumultuous moment
Dr. Jay Bhattacharya, head of the National Institutes of Health and interim leader of the Centers for Disease Control and Prevention, told staff a permanent CDC director could be nominated soon. "I know that it has been such a difficult year," he said.
FDA says billionaire's claims about cancer drug Anktiva are misleading
Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about his company's bladder cancer drug Anktiva.
World
More World
American journalist Shelly Kittleson kidnapped in Iraq
American journalist Shelly Kittleson was kidnapped in Baghdad on Tuesday, according to two sources familiar with the matter as well as an Iraqi official.
Iran war's impact is spreading beyond oil, hitting helium and aluminum
Shortages of helium, a byproduct of natural gas processing, could create problems for semiconductor and medical equipment manufacturers.
Hegseth slated for House testimony amid Iran war pressure, sources say
Defense Secretary Pete Hegseth is tentatively expected to testify publicly before the House Armed Services Committee on April 29, according to two sources familiar with the plans.
Police find drug-smuggling tunnel with rail system and cranes in Spain
Police said two people headed the network, including one person considered to be the "narco-architect" and "mastermind of the tunnels."
Premature babies who escaped Gaza war finally reunited with families
Palestinian parents separated from their premature newborns by the war in Gaza finally get to meet their children for the first time.
Entertainment
More Entertainment
Crew that flew Apache helicopters near Kid Rock's house suspended
Kid Rock posted videos of the helicopters hovering by his Nashville home on social media over the weekend. The Army later confirmed the helicopters were on a training mission.
Taylor Swift sued for trademark infringement
Taylor Swift is being sued by Las Vegas performer Maren Wade who has accused the superstar of trademark infringement over her latest album, "The Life of a Showgirl." Wade is the creator of the "Confessions of a Showgirl" podcast, which started as a column in 2014.
Sharon Stone talks new season of "Euphoria"
Sharon Stone reflected on her legendary career as she discussed joining the cast of "Euphoria," working with the show's creator, Sam Levinson, and how she has advocated for women in the entertainment industry.
Taylor Swift sued for trademark infringement over "The Life of a Showgirl"
A Las Vegas performer has sued Taylor Swift over the title of her hit album "The Life of a Showgirl," alleging it violates the performer's trademark.
Barbie Dream Fest disappoints some attendees
A Barbie Dream Fest event in Fort Lauderdale, Florida, generated backlash from attendees over its allegedly underwhelming experience. Jessica Nova, who drove in from Atlanta for the occasion, joins CBS News to recount her experience.
Technology
More Technology
Technology
Inside Apple's relationship with China
CBS News contributor Patrick McGee joins "The Daily Report" to discuss the codependent relationship between Apple and China, a country that manufactures hundreds of millions of iPhones every year.
Jamie Dimon: JPMorgan could offer prediction market services to investors
The JPMorgan Chase CEO said the bank may one day introduce prediction market features, but said "there's a bunch of stuff we won't do" in that space.
How AI powered robots are helping small farms
From labor shortages to environmental impacts, farmers are looking to AI to help revolutionize the agriculture industry. One California startup, Farm-ng, is tapping into the power of AI and robotics to perform a wide range of tasks, including seeding, weeding and harvesting.
Company tries to make flying car of the future
Many have dreamed of a future with flying cars, eliminating traffic on the morning commute. One company is trying to make that dream a reality. Itay Hod reports.
Judge blocks Pentagon's Anthropic risk label
A judge has temporarily blocked the Pentagon's attempt to designate Anthropic as a supply chain risk. CBS News legal contributor Jessica Levinson joins with analysis.
Science
More Science
Snowy owl, cheetah among 40 species granted international protection
According to a recent report, nearly one in four species catalogued by the CMS are threatened with extinction on a worldwide scale.
Everything to know about NASA's moon mission launching this week
NASA is poised to launch four astronauts April 1 on a historic nine-day trip around the moon and back. Here's everything to know about the Artemis II mission.
Arctic sea ice hits lowest winter level as heat records are shattered worldwide
Arctic sea ice levels are crucial to Earth's climate because, without the ice reflecting sunlight, more heat energy goes into the oceans.
Sharks in Bahamas test positive for caffeine, painkillers, cocaine
Marine biologists found detectable levels of caffeine, cocaine and the over-the-counter painkillers in the blood of 28 sharks.
What to know about the "wild, wild West" of viral peptide claims
Here's what to know about peptides, what they can and can't do, and what's driving viral claims about possible health benefits online.
Crime
More Crime
Crime
Defense in Kirk case questions bullet analysis
Lawyers for the man accused of killing Charlie Kirk are asking to delay a preliminary hearing set for May, arguing the defense team needs time to review ATF analysis they contend "could not" connect a bullet fragment recovered during Kirk's autopsy with the rifle found near the scene of the crime. CBS News legal contributor Jessica Levinson joins to unpack the development.
New details on Tiger Woods arrest report
Tiger Woods had bloodshot eyes, was "sweating profusely" and had "extremely dilated" pupils after a rollover car crash last week, an arrest report shows. CBS News' Shanelle Kaul has the details.
Police find drug-smuggling tunnel with rail system and cranes in Spain
Police said two people headed the network, including one person considered to be the "narco-architect" and "mastermind of the tunnels."
Questions about bullet used to kill Charlie Kirk
Lawyers for Tyler Robinson, the man charged with killing conservative activist Charlie Kirk, are looking to review an analysis that couldn't conclusively connect a bullet fragment recovered during an autopsy to the rifle found near the scene. CBS News' Carter Evans reports.
Lawyers for Kirk suspect ask to delay hearing
A new court filing reveals defense attorneys for Tyler Robinson, the man accused of killing Charlie Kirk, claim an ATF analysis could not conclusively connect the bullet that killed Kirk to the gun Robinson allegedly used. Now the lawyers are asking to delay Robinson's preliminary hearing to review the evidence. Carter Evans reports.
Space
More Space
Smooth countdown continues for Artemis II moon mission
Forecasters continue to predict an 80% chance of favorable weather on Wednesday for the launch of four astronauts on a flight to the moon.
Countdown begins for long-awaited Artemis II moon mission
Countdown clocks began ticking Monday, setting the stage for launch of the Artemis II moon mission early Wednesday evening.
These 4 astronauts are about to make history on flight around the moon
NASA's Artemis II astronauts — three space station veterans and a Canadian rookie — stand out even in an astronaut corps full of super achievers.
Everything to know about NASA's moon mission launching this week
NASA is poised to launch four astronauts April 1 on a historic nine-day trip around the moon and back. Here's everything to know about the Artemis II mission.
Artemis II astronauts say they're "ready to go" for moon launch
The countdown to launch of the Artemis II crew's flight around the moon begins Monday at the Kennedy Space Center in Florida.
Latest Galleries
More Latest Galleries
Notable Deaths in 2026
A look back at the esteemed personalities who've left us this year, who'd touched us with their innovation, creativity and humanity.
Evidence in the Barbara Kendhammer case
Does the evidence show a cover-up, or was Todd Kendhammer wrongfully convicted for the murder of his wife?
The life & near death of prizefighter Christy Salters-Martin
Christy Salters-Martin dominated in the boxing ring but faced her toughest challenger at home.
Timeline: The disappearance of George Smith
Family seeks answers in death of newlywed who disappeared in 2005 while on Mediterranean honeymoon cruise.
Who is Alix Tichelman?
Meet the tattooed beauty charged in the death of Google executive Forrest Hayes.
Latest CBS News Videos
More Latest CBS News Videos
Latest CBS News Videos
Previewing NASA's Artemis II launch
NASA is planning to launch its first crewed mission in over 50 years with its Artemis II flight on Wednesday from Florida's Kennedy Space Center.
Extended interview: Jamie Dimon
JPMorgan Chase CEO Jamie Dimon speaks with "CBS Evening News" anchor Tony Dokoupil about the advancement of artificial intelligence, the war in Iran's effect on the U.S. economy, prediction markets and more.
Boy born with rare defect gets heart transplant
Born with a rare heart defect, Wyatt Lopez was about a year old when he checked into the hospital. It took almost a whole year before he checked back out -- with a tuxedo, a little parade and a brand new heart. Tony Dokoupil has the story.
Jamie Dimon acknowledges struggles across society
The head of JPMorgan Chase is acknowledging that the American dream is slipping out of reach for many. Jamie Dimon spoke to Tony Dokoupil, saying he's on a crusade to change that.
NASA readies Artemis II for historic moon mission
The countdown to launch of the Artemis II mission, NASA's first piloted moonshot in half a century, proceeded smoothly as engineers and technicians prepared the agency's giant Space Launch System rocket and Orion crew capsule for fueling and blastoff. Mark Strassmann has more.